Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-23T05:39:51.177Z Has data issue: false hasContentIssue false
  • English
  • Français

Ketamine in the management of generalised cephalic tetanus

Published online by Cambridge University Press:  26 November 2007

O Obanor ,
H O Osazuwa  and
J E O Amadasun
O Obanor
Affiliation:
Dr Amadasun Ear Care Institute, Westend Hospital, Warri, Nigeria
H O Osazuwa
Affiliation:
Dr Amadasun Ear Care Institute, Westend Hospital, Warri, Nigeria
J E O Amadasun*
Affiliation:
Dr Amadasun Ear Care Institute, Westend Hospital, Warri, Nigeria
*
Address for correspondence: Dr John E O Amadasun, Dr Amadasun Ear Care Institute, Westend Hospital, 1, 25th Street, Airport Road, Effurun PO Box 753, Warri, Nigeria. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

Tetanus is a fatal infection caused by the neurotoxin tetanospasmin released by the vegetative spores of Clostridium tetani. The high mortality rate is related to frequent tetanic fits with laryngeal spasm and airway obstruction. Numerous anticonvulsants are in use, with varying efficacy in controlling fits. This case report highlights the use of ketamine as adjunctive therapy in the management of tetanus.

Case report:

A 20-year-old woman was admitted with a history of recurrent left ear pain, with bloody, purulent discharge, following a self-inflicted injury. She developed tetanic spasms 24 hours after admission. She had received no immunisations. A tracheostomy was established to relieve airway obstruction, and ketamine was added to the medication when breakthrough seizures were refractory to diazepam.

Conclusion:

Ketamine is of proven safety as an anaesthetic agent, especially in cases in which an anaesthetist is not readily available. Its effectiveness in this case, in combination with diazepam, warrants further evaluation.

Keywords

Clostridium TetaniTetanusAirway ObstructionKetamine
Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 122 , Issue 12 , December 2008 , pp. 1389 - 1391
Copyright
Copyright © JLO (1984) Limited 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Thwaites, CL, Farrar, JJ. Preventing and treating tetanus. BMJ 2003;326:117–18CrossRefGoogle ScholarPubMed
2Thwaites, CL. Tetanus. Practical Neurology 2002;2:130–7CrossRefGoogle Scholar
3Sanders, RKM. The management of tetanus. Trop Doct 1996;26:107–15CrossRefGoogle ScholarPubMed
4Humeau, Y, Doussau, F, Grant, NJ, Poulain, B. How botulinum and tetanus block neurotransmitter release. Biochimie 2000;82:427–46CrossRefGoogle ScholarPubMed
5Cook, TM, Protheroe, RT, Handel, JM. Tetanus: a review of the literature. Br J Anaesth 2001;87:477–87CrossRefGoogle ScholarPubMed
6Maramattom, BV, George, AP, Sathyapalan, PA, Puthuran, P. Cephalic tetanus. Neurocrit Care 2006;4:258–9CrossRefGoogle ScholarPubMed
7Bleck, TP. Tetanus: pathophysiology, management and prophylaxis. Dis Mon 1991;37:545–603CrossRefGoogle ScholarPubMed
8Bhatia, R, Probhakar, S, Grover, VK. Tetanus. Neurol India 2002;50:398–407Google ScholarPubMed
9Richardson, JP, Knight, AL. The management and prevention of tetanus. J Emerg Med 1993;11:737–42CrossRefGoogle ScholarPubMed
10Okoromah, CN, Lesi, FE. Diazepam for treating tetanus. Cochrane Database Systemic Review 1;2004:CD003954Google Scholar
11Hesse, IF, Mensah, A, Asante, DK, Lartey, M, Neoquaye, A. Characteristics of adult tetanus in Accra. West Afr J Med 2003;22:291–4Google ScholarPubMed
12Antia-Obong, OE, Ikpatt, HW. Neonatal tetanus in Calabar: a 4-year retrospective study. Nig J Paediatr 1991;18:44–8Google Scholar
13Thwaites, CL, Yen, LM, Loan, HT, Thuy, TTD, Thwaites, GE, Stepniewska, K et al. Magnesium sulphate for the treatment of severe tetanus: a randomized controlled trial. Lancet 2006;368:1436–43CrossRefGoogle Scholar
14Bertilsson, L, Baillie, TA, Revireigo, J. Factors influencing the metabolism of Diazepam. Pharmacol Ther 1990;45:85–91CrossRefGoogle Scholar
15Adams, VHA. The mechanism of action of Ketamine. Anaesthes Reanim 1998;23:60–3Google ScholarPubMed
16Dotson, JW, Ackerman, DL, West, LJ. Ketamine abuse. J Drug Issues 1995;25:751–7CrossRefGoogle Scholar
17Subramaniam, K, Subramaniam, B, Steinbrook, RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systemic review. Anesth Analg 2004;99:482–95CrossRefGoogle Scholar